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There are sex differences in the symptomatology of schizophrenia, and in the response to
antipsychotic treatments. One hallmark symptom of schizophrenia is a deficit in selective
attention. Selective attention can be measured using a latent inhibition (LI) paradigm in
humans; LI can be measured in rodents, and is used as an animal model of the selective
attention deficits observed in schizophrenia. In the current experiments LI was used to
clarify whether selective attention differs between male rats and ovariectomized (OVX)
female rats receiving different estradiol (E2) replacement regimens. An additional aim
was to determine whether haloperidol’s (HAL) facilitation of LI is enhanced by E2. Males
and OVX female rats were trained in a conditioned emotional response LI paradigm.
Females received no E2 replacement, a chronic low dose of E2 via silastic capsule, or
a high phasic dose of E2 via silastic capsule accompanied by E2 (10 µg/kg subcutaneous
(SC)) injections every 4th day. Actual plasma levels of E2 were determined using an
enzyme linked immunosorbent assay. Rats were also administered a vehicle treatment,
a 0.05 mg/kg, or a 0.1 mg/kg IP injection of HAL. Males and OVX females that did not
receive E2 replacement both exhibited LI, but LI was not observed in the low and high
E2 replacement groups. HAL restored LI at a lower dose in the females receiving high
E2 replacement compared to females receiving low E2 replacement, indicating that E2
replacement facilitates HAL in restoring LI.
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INTRODUCTION
There are sex differences in schizophrenia, particularly
in the positive symptoms of this disorder, with women
developing schizophrenia later in life and exhibiting less
severe symptomatology than males (Häfner et al., 1992; Häfner,
2003; Kulkarni et al., 2008). It has been suggested that estrogens
are, in part, responsible for these sex differences, reducing the
frequency of hospital admissions and diminishing the psychotic
symptoms associated with schizophrenia (Kendell et al., 1987;
Matevosyan, 2011). Additionally, there is some evidence that
estrogen is linked to greater efficacy of antipsychotic treatments,
as positive symptoms of schizophrenia are further reduced
when antipsychotics are co-administered with estrogen than
when administered alone (Akhondzadeh et al., 2003; Seeman,
2004). These studies suggest that estrogens protect against the
positive symptoms of schizophrenia and facilitate antipsychotic
treatments in ameliorating these positive symptoms. However, it
remains unclear whether estrogens also have these effects on the
cognitive symptoms of schizophrenia.
One specific cognitive deficit associated with schizophrenia
is disrupted selective attention, which is often assessed using a
latent inhibition (LI) paradigm (Escobar et al., 2002). With LI,
non-reinforced preexposures to a stimulus impair subsequent
conditioning, as these preexposures result in reduced allocation
of attention to that stimulus (Lubow, 1989). However, individ-
uals with acute schizophrenia and schizoptypy have impaired
performance in LI, as repeated non-reinforced preexposures to a
stimulus do not retard conditioning to that stimulus (Lubow et al.,
2000; Schmidt-Hansen et al., 2009; Kaplan and Lubow, 2011).
Individuals with chronic, medicated, schizophrenia do not exhibit
disrupted LI, indicating that antipsychotic treatment ameliorates
this deficit in selective attention (Gray, 1998). It has been argued
that this attentional deficit in schizophrenics, characterized by the
processing of irrelevant stimuli, is a critical contributor to the
symptomatology of this disease (Brébion et al., 1996; Schmidt-
Hansen et al., 2009). Although deficits in selective attention are
a hallmark of schizophrenia, few studies have examined whether
there are sex differences in this cognitive symptom, and how
ovarian hormones may contribute to such differences. Prelimi-
nary research in both schizophrenic and non-schizophrenic pop-
ulations, indicates that males exhibit LI under conditions where
females do not (Vol’f et al., 2001; Kaplan and Lubow, 2011). The
reason for these sex differences is currently unknown, but it is pos-
sible that higher levels of estrogens in females may contribute to
this deficit in selective attention. Additionally, antipsychotic treat-
ments ameliorate the deficiencies in selective attention observed
in schizophrenics, but it remains unclear whether there are sex
differences in this response to antipsychotic medication.
LI can be assessed in both rodents and humans, and LI
paradigms are used to model the attentional deficits associated
Frontiers in Behavioral Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 136 | 1
Almey et al. Latent inhibition, estradiol, and haloperidol
with schizophrenia in animals (Lubow, 2005). Repeated psy-
chostimulant treatment, shown to induce a psychotic state in
humans (Lichlyter et al., 2011), abolishes LI in rats (Moran et al.,
1996; McAllister, 1997; Ruob et al., 1997). Administration of
antipsychotics, including haloperidol (HAL; Feldon and Weiner,
1991; Dunn et al., 1993; Ruob et al., 1997; Weiner et al., 1997;
Arad and Weiner, 2009), among others (Moran et al., 1996; Arad
and Weiner, 2009), facilitate LI in rats. These antipsychotics also
recover LI following a chronic psychostimulant treatment that
abolishes LI (Moser et al., 2000), demonstrating that antipsy-
chotics have similar effects on behavior in the LI paradigm in both
rats and humans.
Experiments examining the effect of estrogens on behavior
of rats in an LI paradigm have yielded contradictory results.
Research from our lab and others indicates that high circulating
levels of estrogens on the conditioning day of an LI paradigm,
either during the proestrus phase of the estrous cycle or in
response to estradiol (E2) replacement following ovariectomy,
are associated with disrupted LI (Arad and Weiner, 2008;
Nofrey et al., 2008; Quinlan et al., 2010). Correspondingly,
low levels of circulating estrogens on the conditioning day of
the same LI paradigm, either during the estrus phase of the
estrous cycle or following ovariectomy, are associated with
intact LI (Arad and Weiner, 2008; Nofrey et al., 2008; Quinlan
et al., 2010). Recent research in humans used a paradigm that
elicited LI in males, but not females (Vol’f et al., 2001; Kaplan
and Lubow, 2011), which suggests that estrogens may also
have detrimental effects on LI in humans. In contrast to these
findings, it has also been shown that elimination of circulating
estrogens via ovariectomy disrupts LI, and estrogen replacement
following ovariectomy eliminates this deficit in LI (Arad and
Weiner, 2009, 2010a,b). This would suggest that estrogens
facilitate, not disrupt, selective attention. Research is needed to
clarify the effect of estrogens on behavior observed in the LI
paradigm.
The current experiments investigated the effects of E2 on
selective attention, and the combined effects of both E2 and
HAL on selective attention. In the first experiment, the behavior
of males and ovariectomized (OVX) females receiving no E2
replacement, a low chronic E2 replacement, or a high phasic E2
replacement, were compared in a conditioned emotional response
LI paradigm. This experiment also administered two doses of the
antipsychotic, HAL (0.05 and 0.1 mg/kg), to determine, in a dose
dependent manner, if the effects of HAL on LI varied based on
sex or E2 replacement. In the first experiment, the aim was to use
E2 replacement doses that mimic levels of E2 observed during the
diestrus and proestrus phases of the estrous cycle. To ensure that
E2 replacement doses achieved the desired levels of circulating E2,
a second study was conducted. That study examined plasma levels
of E2 inOVX rats administered the same E2 regimens as study one
to quantify the plasma concentration of E2 over time following
the E2 replacement regimes used here.
METHODS
SUBJECTS AND SURGERIES
Subjects included 58 male and 179 OVX female Sprague–Dawley
rats weighing approximately 260 g or 240 g, respectively, at
the beginning of the experiment (Charles River Laboratories,
St Constant, QC). Rats were housed in shoebox cages in a
colony room maintained on a reversed 12:12 h light/dark cycle
(lights off at 08:00 h) at approximately 21◦C. Prior to surgery
the animals were housed in pairs (but separated by sex), and
following surgery animals were individually housed. All animals
were handled daily, except during recovery from surgery. Food
was available ad libitum throughout the experiment. Water
was available ad libitum until a day before the start of the
experiment, at which time water bottles were removed from
cages and replaced for 30 min 2 h after the end of the daily
experimental session. All animal handling and testing procedures
were approved by the Animal Research Ethics Committee
(AREC) of Concordia University, and were in accordance with
guidelines established by the Canadian Council on Animal
Care.
Approximately 4–7 days after arrival all animals underwent
surgery. Females were OVX bilaterally through a lumbar inci-
sion, and males received sham surgeries, under isofluorane gas
anesthetic (4% for induction, 2% for maintenance) using aseptic
procedures. Post-surgical care included administration of the
analgesic Anafen (0.1ml, subcutaneous (SC)), the antibiotic peni-
cillin (0.1ml, IM), and physiological saline to prevent dehydration
(3 ml, SC). All rats received a week-long recovery period prior to
the start of the experiments.
DRUG AND HORMONE TREATMENTS
Female rats were assigned to one of three hormone treatment
groups: no E2 replacement, low chronic E2 replacement, or high
phasic E2 replacement. At the time of OVX surgery rats in both
the low and high E2 groups were implanted subcutaneously with
a silastic capsule containing 5% 17-beta E2 (Sigma-Aldrich, St.
Louis, MO) in cholesterol (Sigma). These capsules have been
reported to produce a consistent serum concentration of E2 of
∼20 pg/ml (Mannino et al., 2005), which is within the range
observed in the diestrus phase of the estrous cycle (Overpeck et al.,
1978). Rats in the high phasic E2 treatment group received a SC
injection of E2 (10 µg/kg, SC) dissolved in sesame oil every 4th
day to mimic levels of E2 observed during the proestrus phase of
the cycle. All other rats received oil vehicle injections at this time.
Injections of E2 or vehicle were administered after the session
in the operant chambers on day 3 and 7 of the experiment.
E2 was administered on day 7 so rats would be exposed to E2
approximately 16 h prior to the conditioning session on day 8 of
the experiment.
HAL (diluted in 0.9% saline; Sandoz Inc, QC, Canada) was
administered at 0, 0.05 or 0.1 mg/kg, IP. Doses were selected
following a dose-response pilot study. A pilot study initially used
a range of doses up to 0.2 mg/kg IP of HAL, corresponding to typ-
ical doses administered to males (Moser et al., 2000) and females
(Arad and Weiner, 2009). However, this higher dose induced
sluggishness and torpor in the high E2 female rats, evidenced by
a lack of voluntary movement and diminished reaction to the
footshock. Consequently, the HAL treatments were restricted to
0.05 mg/kg and 0.1 mg/kg. HAL injections were administered to
the rats on the morning of day 8 of the experiment ∼45 min
before the beginning of the conditioning session.
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LATENT INHIBITION
Modular operant test chambers (25 cm wide × 30 cm long ×
30 cm high) contained within sound-attenuating isolation units
were used for all behavioral training and testing (Coulbourne
Instruments, Allentown, PA). Each chamber was equipped with
a center house light (2.8 W) 27 cm above the grid floor in the
center of the left hand wall of the box. A speaker was located
just below the house light, and the grid floor was connected to
a shock module. A water lickometer was located across from the
house light approximately 8 cm above the floor. Every time an
animal licked the water bottle positioned behind the lickometer
an infrared beam was interrupted; the number of infrared beam
interruptions was used as the measure of drinking behavior.
Conditioning chambers and data acquisition were controlled by
a desktop personal computer running Graphic State Notation
software (Coulbourne Instruments, Allentown, PA).
Water restriction began the afternoon prior to the beginning
of behavioral testing, at which point water bottles were removed
from the home cages. The following morning rats were placed
in the operant test chambers and allowed access to the water
for 20 min; this habituation continued for the first 6 days of
the experiment to guarantee that the rats learned to drink water
in the chamber. Rats that did not learn to drink water in the
operant boxes sufficiently (100 licks per session) were omitted
from the study. The number of licks per session was recorded
as baseline drinking behavior. Following habituation, on day 7
of the experiment, water bottles were removed from the operant
chambers. Half of the animals from each group were presented
with 40, 5 sec, 2.5 kHz tones at a volume of ∼65 decibels (Pre-
exposed group, PE). The 40 tone presentations were presented
at 10–50 sec variable intervals over a 22.5 min session in the
operant chambers. The other half of the animals were placed in
the test chambers for an equivalent amount of time but were
not presented with the tone (Not Preexposed group, NPE). On
day 8 all rats underwent a conditioning session where they were
subjected to two pairings of the 5 sec tone directly followed by
a 0.5 mA foot shock for a duration of 1 sec. The intershock
interval was 5 min. On the 9th day the water bottles were returned
to the boxes and animals were re-habituated to drinking in the
chambers.
Testing occurred on the 10th day when water bottles were
present in the operant boxes. After the rats made 100 licks from
the water bottle the tone turned on and remained on until the
rat made 20 additional licks or until 5 min elapsed. This allowed
for measurement of drinking behavior both with and without the
tone. In this paradigm it is hypothesized that since the tone was
previously paired with the footshock, subsequent presentation
of the tone should inhibit drinking. The inhibition of drinking
behavior is expected to be greater in rats in the NPE group,
who were only presented with the tone paired with a footshock.
Conversely, the PE group who heard the tone 40 times without
any consequence should not associate the tone and footshock
as strongly, and their drinking should be less inhibited. This
paradigm is thought to indirectly measure freezing behavior, since
the decrease in drinking following the onset of the tone is typically
the result of the rat freezing, a characteristic fear response (Sotty
et al., 1996). LI is considered to have occurred when the rats in
the PE groupmake 20 licks with the tone on faster than rats in the
NPE group.
E2 PLASMA LEVEL ASSESSMENT
A separate study, using different animals, was conducted to assess
the plasma level accuracy of the E2 treatments used in the behav-
ioral experiment. To examine the efficacy of the silastic capsule
alone, E2 plasma concentrations were examined for 1 month
following its implantation. This experiment included five female
Sprague–Dawley rats that were OVX by a lumbar incision in
the exact manner as described for the previous experiment (see
Section Drug and Hormone Treatments). 1 week post ovariec-
tomy, rats were implanted with a silastic capsule containing 5%
E2 as described in the previous study. Blood was collected from
the tail vein of these rats 1 week following ovariectomy, prior to
E2 implant, and again at 1, 2, 3, and 4 weeks following capsule
implantation.
In addition, to examine the plasma level effects of an acute E2
injection, 17 female Sprague–Dawley rats were OVX by a lumbar
incision and implanted with an E2 containing silastic capsule as
described previously. 10 days following the surgery all rats were
administered a 10 µg/kg IP injection of E2 dissolved in sesame oil
(see Section Drug and Hormone Treatments). E2 was assayed in
sera from rats at six time points across a 24 h period; any one rat
was only used for two time points for ethical reasons. Blood was
collected from the tail vein of five rats just prior to the injection
(baseline), and then again 4 h following the injection. Blood was
collected from six different rats at 8 h and again at 12 h following
the injection. Finally, blood was collected from the final six rats at
16 h and again at 20 h following injection.
Blood was collected in ice-cold vials and immediately
centrifuged. Plasma was stored at −20◦C until being assayed for
E2 using a commercially available ELISA kit (Immuno-Biological
Laboratories Inc., Minneapolis, MI). The assay antibodies have
100% cross-reactivity with E2 and 0.2% and 0.05% cross-
reactivity with estrone and estriol, respectively. The range of the
assay is between 0 and 2000 pg/ml and the reported inter-assay
variation is 7–9%.
STATISTICAL ANALYSES
In an LI protocol the suppression ratios in the PE and NPE groups
are compared to determine if LI has occurred in the PE group.
For each rat, a suppression ratio was calculated as a measure of
LI. This was measured as the time to complete licks 81–100 [A—
without the tone] divided by the sum of the time to complete
licks 81–100 and licks 101–120 [B—with the tone] (A/A + B).
Here, a suppression ratio of 0.5 indicates no suppression of licking
during the tone (i.e., no conditioned response to the tone), while
a suppression ratio of 0.003 indicates full suppression of licking
in the presence of the tone. Suppression ratios for the rats in each
group were averaged; LI is considered to have occurred when the
rats in the PE group have significantly higher suppression ratio
than that in those in the NPE group.
Data from the males and females were analyzed separately,
as hormone treatment level was a factor in the analyses for the
females but not for the males. Suppression ratios from the males
were analyzed using a 2 × 3 between subjects ANOVA, and
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suppression ratios for the females were analyzed using a 2 × 3
× 3 between subjects ANOVA. Additionally, planned orthogonal
contrasts were run on all of the data, comparing the PE and NPE
groups in each condition to determine if LI occurred. T-tests
were used for all orthogonal contrasts, and Cohen’s d effect size
calculations were run for each t-test. Data from study 2, examin-
ing circulating levels of E2 in OVX females with E2 replacement
were not statistically analyzed, as these data were meant to be
descriptive.
RESULTS
LATENT INHIBITION
Male rats exhibited LI regardless of HAL treatment (Figure 1A).
A 2 × 3 ANOVA, with main factor of exposure (PE vs NPE) and
HAL dose (vehicle, 0.05 mg/kg, 0.1 mg/kg), was used to analyze
data from the male rats. This ANOVA revealed a significant main
effect of exposure, F(1, 52) = 19.41, p < 0.001. This main effect
was due to significantly higher suppression ratios in the PE group,
compared to the NPE group, indicating that LI occurred. Orthog-
onal contrasts demonstrated that the PE rats had significantly
higher suppression ratios than the NPE rats in the vehicle group
(t(20) = 2.42, p = 0.023, d = 1.11), the 0.05 mg/kg HAL group
(t(16)= 3.13, p = 0.004, d = 1.66), and the 0.1 mg/kg HAL group
(t(16) = 3.77, p = 0.002, d = 1.88). This shows that male rats
developed LI regardless of the dose of HAL.
A 2 × 3 × 3 ANOVA, with main factors of exposure (PE vs
NPE), E2 replacement (no E2, low E2, and high E2), and HAL
dose (vehicle, 0.05 mg/kg, 0.1 mg/kg), was used to analyze data
from the female rats. There was a main effect of exposure, F(1,
173) = 27.37, p < 0.001, a main effect of HAL treatment, F(2,
173)= 6.12, p = 0.003), and an interaction between exposure and
HAL treatment, F(4, 173)= 2.74, p= 0.030. Orthogonal contrasts
demonstrated that OVX females receiving no E2 replacement in
the PE group had significantly higher suppression ratios than NPE
group in the vehicle condition (t(25)= 2.32, p= 0.029, d = 0.93),
the 0.05 mg/kg HAL condition (t(22) = 2.45, p = 0.023, d =
1.04), and the 0.1 mg/kg condition (t(16) = 2.92, p = 0.010, d
= 1.46; Figure 1B). These OVX females showed a similar pattern
of results to the male rats, exhibiting LI regardless of the dose
of HAL. Orthogonal contrasts demonstrated that OVX rats with
FIGURE 1 | (A) Suppression ratios for males; LI was observed in rats treated
with 0.05 and 0.1 mg/kg HAL. (B) Suppression ratios for OVX females
receiving no E2 replacement; LI was observed in rats treated with vehicle,
0.05 mg/kg, and 0.1 mg/kg HAL. (C) Suppression ratios for ovariectomized
(OVX) females receiving high E2 replacement; LI was observed in rats
treated with 0.05 mg/kg and 0.1 mg/kg HAL. (D) Suppression ratios for OVX
females receiving low E2 replacement: LI was observed in rats treated with
the 0.1 mg/kg HAL. The error bars represent standard error of the mean, the
n for each group is depicted on the bar representing that group.
(* = p < 0.05).
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either high or low E2 replacement (Figures 1C,D, respectively)
did not develop LI when administered a vehicle injection (d =
0.33 and d = 0.62, respectively). At the 0.05 mg/kg dose of HAL,
rats in the high E2 group exhibited LI, that is, the PE rats exhibited
significantly higher suppression ratios than the NPE rats (t(10)
= 2.35, p = 0.03, d = 1.11). In contrast, rats receiving low E2
replacement and the 0.05 mg/kg dose of HAL did not express LI
insofar as there was no difference in suppression ratios between
PE and NPE groups (d = 0.71). Finally, the 0.1 mg/kg dose of
HAL recovered LI in rats receiving both the high and low E2
replacement (t(11) = 2.69, p = 0.02, d = 1.20, and t(10) = 2.49,
p = 0.02, d = 1.21, respectively).
E2 PLASMA LEVELS
The plasma concentrations of E2 following implantation of the
silastic capsule were determined (Figure 2A). Data are expressed
as mean ± standard error of the mean. Female rats had relatively
low levels of E2 after ovariectomy, prior to implantation of the
capsule (6.51 ± 1.38 pg/ml). There was an increase in the plasma
concentration of E2 at week 1 (37.54 ± 5.67 pg/ml) and week 2
A
B
FIGURE 2 | Estradiol (E2) plasma levels following: (A) ovariectomy and
implantation of a silastic capsule containing 5% 17-beta E2 and cholesterol.
(B) Ovariectomy, implantation of a silastic capsule, and a 10 µg/kg SC
injection of E2, dissolved in sesame oil. The error bars represent standard
error of the mean.
(38.25± 11.72 pg/ml) following capsule implantation. Plasma E2
levels slowly decreased at week 3 (29.41 ± 16.58 pg/ml) and week
4 (17.09 ± 4.01 pg/ml). These plasma concentrations are in the
range of the average plasma level of E2 during diestrus in the rat
(Overpeck et al., 1978).
A second experiment examined the plasma concentration of
E2 in response to a silastic capsule implant paired with a 10
µg/kg injection of E2 (Figure 2B). Rats had similar E2 plasma
concentrations following capsule implantation as was observed
in the previous experiment (28.66 ± 5.91 pg/ml), confirming the
efficacy of the capsules. 4 h following the E2 injection the average
plasma level of E2 increased markedly to 208.79 ± 12.03 pg/ml.
The plasma concentration of E2 had decreased to 79.00 ± 4.30
pg/ml 8 h following the injection, and was maintained close to
that level 12 h following injection (83.26 ± 24.08 pg/ml). 16 h
after the injection plasma concentrations of E2 dropped to 51.30
± 11.68 pg/ml, and 20 h following the injection plasma levels were
down to 39.18 ± 8.97 pg/ml (Figure 2B). The average plasma
concentration across the 20 h period following E2 injection is in
the range of plasma levels observed during the proestrus phase of
the cycle in the rat (Overpeck et al., 1978).
DISCUSSION
These experiments demonstrate that physiologically relevant lev-
els of E2 disrupt LI, and this disruption can be reversed by an
acute injection of HAL administered prior to the conditioning
session. Furthermore, the lower dose of HAL (0.05 mg/kg) was
sufficient to restore LI in the high E2 replacement rats, but not in
those with low E2 replacement. This indicates that estrogens may
facilitate the effects of HAL, as HAL is more effective in females
with high levels of E2. Females are more responsive to antipsy-
chotics than males (Seeman, 2004), and these results suggest that
estrogens contribute to this sex difference differing responses to
HAL in males and females in an LI paradigm. These experiments
also show that the dose and method of E2 capsule replacement
used here results in sustained low levels of E2 similar to that
observed during diestrus for up to 4 weeks. Furthermore, the
single injection of E2 shows a peak plasma concentration within
4 h following injection, returning to baseline levels within 20 h
mimicking estrogen levels occurring during proestrus (Overpeck
et al., 1978).
E2 AND LATENT INHIBITION
The results presented here are in accordance with previous
research from this lab indicating that estrogens disrupt LI in
females under conditions where LI is observed in males and
in OVX female rats (Nofrey et al., 2008; Quinlan et al., 2010).
When OVX rats are administered E2 replacement alone, there
is no difference between suppression ratios in the PE and NPE
groups, indicating that LI did not occur (Figure 1). We did
not observe a difference between PE and NPE females due to
low suppression ratios in the PE group, suggesting that the
E2 treated females are unable to ignore the tone that should
have been rendered irrelevant through multiple non-reinforced
presentations. In contrast both male rats and OVX female rats
given no E2 replacement have significantly higher suppression
ratios in the PE group compared to the NPE group, indicating
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that LI did occur. Taken together these findings demonstrate that
estrogen has detrimental effects on selective attention, impairing
the ability to disregard irrelevant stimuli in the environment.
In contrast to these findings there is a body of research indicat-
ing that ovariectomy induces deficits in LI while E2 facilitates LI
(Arad and Weiner, 2009, 2010a,b). The reason for these contra-
dictory results is unclear, although there are methodological dif-
ferences which likely contributed. In the conditioned emotional
response LI paradigm employed by others (Arad and Weiner,
2009, 2010a,b) they use a 10 sec, 80 dB tone during pre-exposure
and conditioning compared to the 5 sec 65 dB tone used in our
experiments. Therefore their stimuli is much more salient, since
it is louder and longer, which could impact whether the stimuli
is rendered irrelevant during the preexposure phase, and the
association formed during the conditioning phase. Additionally,
our high E2 replacement dose is much lower than the E2 dose
used by other researchers in the field. In this study, efforts were
made to use an E2 replacement regime that mimicked the estrous
cycle of the rats. Study two demonstrates that plasma levels of E2
following capsule implantation, and capsule implantation com-
bined with an acute injection E2, are within the range observed
during the diestrus and proestrus phases of the cycle, respectively
(Figure 2; Overpeck et al., 1978), so the results of this experiment
should mimic the effects of endogenous estrogens. This difference
in the E2 replacement doses may provide a partial explanation
for the contradictory findings on the effects of E2 on selective
attention. In addition, LI as employed here is affected by many
variables including level of conditioning to the tone-footshock
pairing as well as general anxiety levels. It is possible that some
of the effects observed here could be attributed to these as well as
other variables unrelated to selective attention.
HALOPERIDOL AND LI
It is well established that HAL can facilitate LI in male rats (Moser
et al., 2000), and more recently research has demonstrated that
this is also true for female rats (Arad and Weiner, 2009). The
findings of the current experiments correspond to this, as the
highest dose of HAL restores LI in females receiving both low and
high E2 replacement. More interestingly these results indicate that
E2 actually enhances the effects of HAL on LI, as the lower dose of
HAL was sufficient to restore LI in the high E2 replacement group,
but not in the low E2 replacement group. In these experiments,
and others (Arad and Weiner, 2008; Nofrey et al., 2008; Quinlan
et al., 2010), elevated levels of circulating estrogens are detrimen-
tal to LI in female rats, but these findings indicate that E2 replace-
ment also facilitates the effects of HAL treatment in facilitating LI.
There is evidence that this might be the case in humans as well. Sex
differences in LI are observed in humans, where males exhibit LI
under conditions where females do not (Vol’f et al., 2001; Kaplan
and Lubow, 2011), and the peak of estrogens in the menstrual
cycle is correlated with distractibility and an inability to disen-
gage from irrelevant stimuli (Beaudoin and Marrocco, 2005).
Additionally, research in humans indicates that antipsychotic
treatments are more effective in females, as schizophrenic women
require significantly lower doses of antipsychotic drugs to alleviate
their symptoms than men (Usall et al., 2007). Furthermore E2
administered in conjunction with antipsychotic treatment results
in better treatment outocomes in schizophrenia (Akhondzadeh
et al., 2003; Seeman, 2004).
This study did not examine the neurobiological underpinnings
of the behaviors observed in the LI paradigm. However, previous
research has implicated dopaminergic transmission in various
nuclei of the mesocorticolimbic system in LI. In the prefrontal
cortex (PFC), lesions and local infusion of a dopamine antag-
onist enhance LI (Broersen et al., 1996; George et al., 2010).
Lesions of the nucleus accumbens (NAc) abolish LI (Weiner et al.,
1997), and dopaminergic activity in the anterior striatum (STR)
is positively correlated with behavior in an LI task (Jeanblanc
et al., 2003). Interestingly, estrogens have been shown to alter
dopamine transmission in these nuclei of the mesocorticolim-
bic system. Specifically, estrogens increase dopamine levels and
dopamine 2 receptor (D2R) density in the NAc (Thompson and
Moss, 1994; Le Saux et al., 2006), increase dopamine activity
and D2R density in the STR (Becker and Rudick, 1999; Landry
et al., 2002), and increase dendritic spine and dopamine one
receptor density in the PFC (Lévesque andDi Paolo, 1989;Wallace
et al., 2006). Estrogen-induced changes in dopamine transmission
in the mesocorticolimbic system could be partially responsible
for the detrimental effects of estrogens on behavior in the LI
paradigm. Additionally, HAL exerts its effects by antagonizing
D2Rs, and E2 replacement increases in D2R density in the STR
and NAc (Landry et al., 2002; Le Saux et al., 2006). Therefore,
E2 replacement would increase binding sites for HAL, providing
one possible explanation for estrogens’ facilitatory effects on this
antipsychotic. Future research should investigate these hypotheses
to determine whether estrogen-induced changes in dopaminergic
transmission in the mesocorticolimbic system are responsible for
the E2-induced reductions in selective attention, and increased
response to HAL treatment, observed in this study.
CONCLUSION
E2 replacement administered to OVX females abolishes LI under
conditions where it is observed in males, but despite these detri-
mental effects on LI, E2 facilitates HAL to enhance LI. These
experiments indicate that estrogens are, in part, responsible for
sex differences in LI and the response to HAL. Further research is
needed to extend these findings from HAL to other antipsychotic
treatments, and to elucidate the specific neurobiological mecha-
nisms responsible for estrogens effects on LI and the response to
antipsychotic treatments.
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